Lost in translation? Moving contingency management and cognitive behavioral therapy into clinical practice

Annals of the New York Academy of Sciences

Volumn 1327, Issue 1, 2014, Pages 94-111

  Carroll, Kathleen M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cognitive behavioral therapy; Contingency management; Dissemination; Stage model

Indexed keywords

ADAPTATION; ARTICLE; BEHAVIOR THERAPY; CLINICAL PRACTICE; COGNITIVE THERAPY; COMMUNITY; CONTINGENCY MANAGEMENT; COST; DISEASE MANAGEMENT; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HUMAN; IDEOLOGY; MASS COMMUNICATION; PERFORMANCE; STANDARD; BEHAVIOR, ADDICTIVE; EVIDENCE BASED MEDICINE; MULTIMODALITY CANCER THERAPY; NATIONAL HEALTH ORGANIZATION; PRACTICE GUIDELINE; PSYCHOLOGICAL MODEL; PSYCHOLOGICAL THEORY; PSYCHOLOGY; REINFORCEMENT; SUBSTANCE-RELATED DISORDERS; TRANSLATIONAL RESEARCH; UNITED STATES;

BEHAVIOR, ADDICTIVE; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; HUMANS; MODELS, PSYCHOLOGICAL; NATIONAL INSTITUTE ON DRUG ABUSE (U.S.); PRACTICE GUIDELINES AS TOPIC; PSYCHOLOGICAL THEORY; REINFORCEMENT, SOCIAL; SUBSTANCE-RELATED DISORDERS; TRANSLATIONAL MEDICAL RESEARCH; UNITED STATES;

EID: 84915793160     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12501     Document Type: Article

References (216)

1. Hoffman, K.A. & D. McCarty. 2013. "Improving the quality of addiction treatment." In Interventions for Addiction: Comprehensive Addictive Behaviors and Disorders. Vol. 3. P.M. Miller, Ed.: 579-588. San Diego, CA: Academic Press.
2. Institute of Medicine. 2006. Improving the Quality of Health Care for Mental and Substance Use Conditions. Washington DC: The National Academies Press.
3. Vocci, F.J., J. Acri & A. Elkashef. 2005. Medication development for addictive disorders: the state of the science. Am. J. Psychiatry 162: 1432-1440.
4. Gastfriend, D.R. 2011. Intramuscular extended-release naltrexone: current evidence. Ann. N.Y. Acad. Sci. 1216: 144-166.
5. O'Malley, S.S. & J.C. Froehlich. 2003. Advances in the use of naltrexone: an integration of preclinical and clinical findings. Recent Dev. Alcohol. 16: 217-245.
6. Jonas, D.E. et al. 2014. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA 311: 1889-1900.
7. Anton, R.F. et al. 2006. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295: 2003-2017.
8. National Institute on Drug Abuse. 2007. Principles of Drug Addiction Treatment: A Research Based Guide. Bethesda, MD: NIDA.
9. Carroll, K.M. & L.S. Onken. 2005. Behavioral therapies for drug abuse. Am. J. Psychiatry 162: 1452-1460.
10. Babor, T.F. et al. 2007. Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse. Subst. Abus. 28: 7-30.
11. Miller, W.R. 2000. Rediscovering fire: small interventions, large effects. Psychol. Addict. Behav. 14: 6-18.
12. Burke, B.L., H. Arkowitz & M. Menchola. 2003. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J. Consult. Clin. Psychol. 71: 843-861.
13. Rubak, S. et al. 2005. Motivational interviewing: a systematic review and meta-analysis. Br. J. Gen. Pract. 55: 305-312.
14. Heckman, C.J., B.L. Egleston & M.T. Hofmann. 2010. Efficacy of motivational interviewing for smoking cessation: a systematic review and meta-analysis. Tob. Control 19: 410-416.
15. Jensen, C.D. et al. 2011. Effectiveness of motivational interviewing interventions for adolescent substance use behavior change: a meta-analytic review. J. Consult. Clin. Psychol. 79: 433-440.
16. Stanton, M.D. & W.R. Shadish. 1997. Outcome, attrition, and family-couples treatment for drug abuse: a meta-analysis and review of the controlled, comparative studies. Psychol. Bull. 122: 170-191.
17. Henggeler, S.W. et al. 1996. Eliminating (almost) treatment dropout of substance abusing or dependent delinquents through home-based multisystemic therapy. Am. J. Psychiatry 153: 427-428.
18. Dutra, L. et al. 2008. A meta-analytic review of psychosocial interventions for substance use disorders. Am. J. Psychiatry 165: 179-187.
19. Institute of Medicine. 1998. Bridging the Gap between Practice and Research: Forging Partnerships with Community-Based Drug and Alcohol Treatment. Washington DC: National Academy Press.
20. Regier, D.A. et al. 1993. The de facto US mental health and addictive disorders service system. Epidemiological catchment area prospective one-year prevalence rates of disorders and services. Arch. Gen. Psychiatry 50: 85-91.
21. Norquist, G. & D.A. Regier. 1996. The epidemiology of psychiatric disorders and the de facto mental health care system. Annu. Rev. Med. 47: 473-479.
22. McGlynn, E.A. et al. 2003. The quality of health care delivered to adults in the United States. N. Engl. J. Med. 348: 2635-2645.
23. D'Aunno, T. & H.A. Pollack. 2002. Changes in methadone treatment practices: results from a national panel study, 1988-2000. JAMA 288: 850-856.
24. Stewart, M.T. & C.H. Horgan. 2011. Health services and financing of treatment. Alcohol Res. Health 33: 389-394.
25. Miller, W.R. et al. 2006. Disseminating evidence-based practices in substance abuse treatment: a review with suggestions. J. Subst. Abuse Treat. 31: 25-39.
26. McLellan, A.T., D. Carise & H.D. Kleber. 2003. Can the national addiction treatment infrastructure support the public's demand for quality care? J. Subst. Abuse Treat. 25: 117-121.
27. Horgan, C.M. & H.J. Levine. 1999. "The substance abuse treatment system: What does it look like and whom does it serve?" In Bridging the Gap between Practice and Research: Forging Partnerships with Community-Based Drug and Alcohol Treatment. S. Lamb, M.R. Greenlick & D. McCarty, Eds.: 186-197. Washington DC: National Academy Press.
28. McLellan, A.T. 2006. "What we need is a system: creating a responsive and effective substance abuse treatment system." In Rethinking Substance Abuse: What the Science Shows and What We Should Do About It. W.R. Miller & K.M. Carroll, Eds.: 275-292. New York: Guilford.
29. Knudsen, H.K., L.J. Ducharme & P.M. Roman. 2008. Clinical supervision, emotional exhaustion, and turnover intention: a study of substance abuse treatment counselors in the Clinical Trials Network of the National Institute on Drug Abuse. J. Subst. Abuse Treat. 35: 387-395.
30. Olmstead, T.A. et al. 2012. Counselor training in several evidence-based psychosocial addiction treatments in private US substance abuse treatment centers. Drug Alcohol Depend. 120: 149-154.
31. McCarty, D. et al. 2007. Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: characteristics, opinions, and beliefs. Psych. Serv. 58: 181-190.
32. McGovern, M.P. et al. 2004. A survey of clinical practices and readiness to adopt evidence-based practices: Dissemination research in an addiction treatment system. J. Subst. Abuse Treat. 26: 305-312.
33. Rieckmann, T. et al. 2007. Client and counselor attitudes toward the use of medications for treatment of opioid dependence. J. Subst. Abuse Treat. 32: 207-215.
34. Saxon, A.J. & D. McCarty. 2005. Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs. Pharmacol. Ther. 108: 119-128.
35. Miller, W.R. & S. Rollnick. 2002. Motivational Interviewing: Preparing People for Change (2nd ed). New York: Guilford Press.
36. Rogers, E.M. 1995. Diffusion of Innovations, Fourth Edition. New York: The Free Press.
37. Abele, M. et al. 2014. Teaching Motivational Interviewing Skills to Psychiatry Trainees: Findings of a National Survey. Acad. Psychiatry. May 15. [Epub ahead of print].
38. Lindhardt, C.L. et al. 2014. Training in motivational interviewing in obstetrics: a quantitative analytical tool. Acta obstetricia et gynecologica Scandinavica 93: 698-704.
39. Imel, Z.E. et al. 2014. Evaluating therapist adherence in motivational interviewing by comparing performance with standardized and real patients. J. Consult. Clin. Psychol. 82: 472-481.
40. Martino, S. et al. 2011. Teaching community program clinicians motivational interviewing using expert and train-the-trainer strategies. Addiction 106: 428-441.
41. Miller, W.R. et al. 2004. A randomized trial of methods to help clinicians learn motivation interviewing. J. Consult. Clin. Psychol. 72: 1050-1062.
42. Miller, W.R. & S. Rollnick. 2014. The effectiveness and ineffectiveness of complex behavioral interventions: impact of treatment fidelity. Contemp. Clin. Trials. 37: 234-241.
43. Petry, N.M. et al. 2008. Serious adverse events in randomized psychosocial treatment studies: safety or arbitrary edicts? J. Consult. Clin. Psychol. 76: 1076-1082.
44. Poling, J. et al. 2006. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Arch. Gen. Psychiatry 63: 219-228.
45. Kosten, T. et al. 2003. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug Alcohol Depend. 70: 315-325.
46. Rounsaville, B.J., K.M. Carroll & L.S. Onken. 2001. A stage model of behavioral therapies research: Getting started and moving on from Stage I. Clin. Psychol. Sci. Pract. 8: 133-142.
47. Onken, L.S. et al. 2013. Re-envisioning clinical science: Unifying the discipline to improve the public health. Clin. Psychol. Sci. Pract. 2: 22-34.
48. Carroll, K.M. & B.J. Rounsaville. 2003. Bridging the gap: a hybrid model to link efficacy and effectiveness research in substance abuse treatment. Psychiatr. Serv. 54: 333-339.
49. Fixsen, D.L. et al. 2005. Implementation Research: A Synthesis of the Literature. Tampa, FL: University of South Florida, Louis de la Parte Florida Mental Health Institute, the National Implementation Research Network (FMHI Publication #231).
50. Bigelow, G.E. & K. Silverman. 1999. "Theoretical and empirical foundations of contingency managment treatments for drug abuse." In Motivating Behavior Change among Illicit Drug Users. S.T. Higgins & K. Silverman, Eds.: 15-31. Washington DC: American Psychological Association.
51. Stitzer, M.L. & G.E. Bigelow. 1978. Contingency management in a methadone maintenance program: Availability of reinforcers. Int. J. Addict. 13: 737-746.
52. Bigelow, G.E., M.L. Stitzer & I.A. Liebson. 1984. "The role of behavioral contingency management in drug abuse treatment." In Behavioral Intervention Techniques in Drug Abuse Treatment. J. Grabowski, M.L. Stitzer & J.E. Henningfield, Eds.: 36-52. Rockville, MD: NIDA.
53. Stitzer, M.L. et al. 1986. Effect of methadone dose contingencies on urinalysis test results of polydrug abusing methadone maintenance patients. Drug Alcohol Depend. 18: 341-348.
54. Iguchi, M.Y. et al. 1988. Contingency management in methadone maintenance: effects of reinforcing and aversive consequences on illicit polydrug use. Drug Alcohol Depend. 22: 1-7.
55. Rounsaville, B.J. 1995. "Can psychotherapy rescue naltrexone treatment of opioid addiction?" In Potentiating the Efficacy of Medications: Integrating Psychosocial Therapies with Pharmacotherapies in the Treatment of Drug Dependence. L.S. Onken & J.D. Blaine, Eds.: 37-52. Rockville, MD: NIDA.
56. Greenstein, R.A., P.J. Fudala & C.P. O'Brien. 1997. "Alternative pharmacotherapies for opiate addiction." In Comprehensive Textbook of Substance Abuse. J.H. Lowinson et al., Eds.: 415-425. New York: Williams & Wilkins.
57. Grabowski, J. et al. 1979. Effects of contingent payments on compliance with a naltrexone regimen. Am. J. Drug Alcohol Abuse 6: 355-365.
58. Meyer, R.E. et al. 1976. A behavioral paradigm for the evaluation of narcotic antagonists. Arch. Gen. Psychiatry 33: 371-377.
59. Azrin, N.H. 1976. Improvements in the community-reinforcement approach to alcoholism. Behav. Res. Ther. 14: 339-348.
60. Budney, A.J. & S.T. Higgins. 1998. A Community Reinforcement Plus Vouchers Approach: Treating Cocaine Addiction. Rockville, MD: NIDA.
61. Higgins, S.T. et al. 1991. A behavioral approach to achieving initial cocaine abstinence. Am. J. Psychiatry 148: 1218-1224.
62. Higgins, S.T. et al. 1993. Achieving cocaine abstinence with a behavioral approach. Am. J. Psychiatry 150: 763-769.
63. Higgins, S.T. et al. 1994. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch. Gen. Psychiatry 51: 568-576.
64. Higgins, S.T. et al. 2000. Contingent reinforcement increases cocaine abstinence during outpatient treatment and one year follow-up. J. Consult. Clin. Psychol. 68: 64-72.
65. Silverman, K. et al. 2002. A reinforcement-based therapeutic workplace for the treatment of drug abuse: three year abstinence outcomes. Exp. Clin. Psychopharmacol. 10: 228-240.
66. Silverman, K. et al. 2001. A reinforcement-based therapeutic workplace for the treatment of drug abuse: six-month abstinence outcomes. Exp. Clin. Psychopharmacol. 9: 14-23.
67. Silverman, K. et al. 1996. Voucher-based reinforcement of attendance by unemployed methadone patients in a job skills training program. Drug Alcohol Depend. 41: 197-207.
68. Schumacher, J.E. et al. 2000. Abstinent-contingent housing and treatment retention among crack-cocaine-dependent homeless persons. J. Subst. Abuse Treat. 19: 81-88.
69. Milby, J.B. et al. 2000. Initiating abstinence in cocaine abusing dually diagnosed homeless persons. Drug Alcohol Depend. 60: 55-67.
70. Milby, J.B. et al. 1996. Sufficient conditions for effective treatment of substance abusing homeless persons. Drug Alcohol Depend. 43: 39-47.
71. Silverman, K. et al. 1996. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch. Gen. Psychiatry 53: 409-415.
72. Silverman, K. et al. 1996. Increasing opiate abstinence through voucher-based reinforcement therapy. Drug Alcohol Depend. 41: 157-165.
73. Krishnan-Sarin, S. et al. 2006. Contingency management for smoking cessation in adolescent smokers. Exp. Clin. Psychopharmacol. 14: 306-310.
74. Krishnan-Sarin, S. et al. 2013. An exploratory randomized controlled trial of a novel high-school-based smoking cessation intervention for adolescent smokers using abstinence-contingent incentives and cognitive behavioral therapy. Drug Alcohol Depend. 132: 346-351.
75. Henggeler, S.W. et al. 1997. Multisystemic therapy with violent and chronic juvenile offenders and their families: the role of treatment fidelity. J. Consult. Clin. Psychol. 65: 821-833.
76. Henggeler, S.W. et al. 2002. Transporting efficacious treatments to field settings: the link between supervisory practices and therapist fidelity in MST programs. J. Clin. Child Adolesc. Psychol. 31: 155-167.
77. Henggeler, S.W. et al. 2007. If you build it, they will come: statewide practitioner interest in contingency management for youths. J. Subst. Abuse Treat. 32: 121-131.
78. Henggeler, S.W. et al. 2008. Statewide adoption and initial implementation of contingency management for substance-abusing adolescents. J. Consult. Clin. Psychol. 76: 556-567.
79. Henggeler, S.W. et al. 2008. Promoting the implementation of an evidence-based intervention for adolescent marijuana abuse in community settings: testing the use of intensive quality assurance. J. Clin. Child Adolesc. Psychol. 37: 682-689.
80. Henggeler, S.W. et al. 2013. Evaluating training methods for transporting contingency management to therapists. J. Subst. Abuse Treat. 45: 466-474.
81. Letourneau, E.J. et al. 2013. Two-year follow-up of a randomized effectiveness trial evaluating MST for juveniles who sexually offend. J. Fam. Psychol. J. Div. Fam. Psychol. Am. Psychol. Assoc. 27: 978-985.
82. Haynes, R.B., D.W. Taylor & D.L. Sackett. 1979. Compliance in Health Care. Baltimore, MD: Johns Hopkins University Press.
83. Rigsby, M.O. et al. 2000. Cue dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. J. Gen. Intern. Med. 15: 841-847.
84. Rosen, M.I. et al. 2007. Improved adherence with contingency management. AIDS Patient Care STDS 21: 30-40.
85. Sorensen, J.L. et al. 2007. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend. 88: 54-63.
86. Preston, K.L. et al. 1999. Improvement in naltrexone treatment compliance with contingency management. Drug Alcohol Depend. 54: 127-135.
87. Carroll, K.M. et al. 2002. Contingency management to enhance naltrexone treatment of opioid dependence: a randomized clinical trial of reinforcement magnitude. Exp. Clin. Psychopharmacol. 10: 54-63.
88. Carroll, K.M. et al. 2001. Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement. Arch. Gen. Psychiatry 58: 755-761.
89. Petry, N.M. et al. 2012. Financial reinforcers for improving medication adherence: findings from a meta-analysis. Am. J. Med. 125: 888-896.
90. Gritz, E.R., B.A. Toll & G.W. Warren. 2014. Tobacco use in the oncology setting: advancing clinical practice and research. Cancer Epidemiol. Biomarkers Prev. 23: 3-9.
91. Heil, S.H. & S.T. Higgins. 2012. The scientific and ethical rationale for using incentives to promote contraceptive use among drug-abusing women. Addiction 107: 1044-1046.
92. Higgins, S.T. et al. 2012. Incentives and health: an introduction. Prevent. Med. 55(Suppl.): S2-S6.
93. Heil, S.H. et al. 2008. Effects of voucher-based incentives on abstinence from cigarette smoking and fetal growth among pregnant women. Addiction 103: 1009-1018.
94. Higgins, S.T. et al. 2012. Financial incentives for smoking cessation among pregnant and newly postpartum women. Prevent. Med. 55(Suppl.): S33-S40.
95. Prendergast, M. et al. 2006. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 101: 1546-1560.
96. Lussier, J.P. et al. 2006. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 101: 192-203.
97. Griffith, J.D. et al. 2000. Contingency management in outpatient methadone treatment: a meta-analysis. Drug Alcohol Depend. 58: 55-66.
98. Petry, N.M. 2010. Contingency management treatments: controversies and challenges. Addiction 105: 1507-1509.
99. Kirby, K.C. et al. 2006. Substance abuse treatment providers' beliefs and objections regarding contingency management: implications for dissemination. Drug Alcohol Depend. 85: 19-27.
100. Amodeo, M. et al. 2011. Barriers to implementing evidence-based practices in addiction treatment programs: comparing staff reports on motivational interviewing, adolescent community reinforcement approach, assertive community treatment, and cognitive-behavioral therapy. Eval. Program Plann. 34: 382-389.
101. Lundgren, L. et al. 2012. Barriers to implementation of evidence-based addiction treatment: a national study. J. Subst. Abuse Treat. 42: 231-238.
102. Carroll, K.M. & B.J. Rounsaville. 2007. A vision of the next generation of behavioral therapies research in the addictions. Addiction. 102: 850-862; discussion 863-859.
103. Petry, N.M. et al. 2000. Give them prizes and they will come: contingency management treatment of alcohol dependence. J. Consult. Clin. Psychol. 68: 250-257.
104. Petry, N.M. & B. Martin. 2002. Low-cost contingency management for treating cocaine- and opioid abusing methadone patients. J. Consult. Clin. Psychol. 70: 398-405.
105. Petry, N.M. 2000. A comprehensive guide to the application of contingency management procedures in clinical settings. Drug Alcohol Depend. 58: 9-25.
106. Petry, N.M. & F. Simcic. 2002. Recent advances in the dissemination of contingency management techniques: clinical and research perspectives. J. Subst. Abuse Treat. 23: 81-86.
107. Petry, N.M. & M.J. Bohn. 2003. Fishbowls and candy bars: using low-cost incentives to increase treatment retention. Sci. Pract. Perspect. 2: 55-61.
108. Petry, N.M., B. Martin & C. Finocche. 2001. Contingency management in group treatment: a demonstration project in an HIV drop-in center. J. Subst. Abuse Treat. 21: 89-96.
109. Petry, N.M. et al. 2006. Contingency management treatments: reinforcing abstinence versus adherence with goal-related activities. J. Consult. Clin. Psychol. 74: 592-601.
110. Petry, N.M., J.D. Ford & D. Barry. 2011. Contingency management is especially efficacious in engendering long durations of abstinence in patients with sexual abuse histories. Psychol. Addict. Behav. 25: 293-300.
111. Petry, N.M., C.J. Rash & C.J. Easton. 2011. Contingency management treatment in substance abusers with and without legal problems. J. Am. Acad. Psychiatry Law 39: 370-378.
112. Petry, N.M., S.M. Alessi & C.J. Rash. 2013. A randomized study of contingency management in cocaine-dependent patients with severe and persistent mental health disorders. Drug Alcohol Depend. 130: 234-237.
113. Petry, N.M. & K.M. Carroll. 2013. Contingency management is efficacious in opioid-dependent outpatients not maintained on agonist pharmacotherapy. Psychol. Addict. Behav. 27: 1036-1043.
114. Petry, N.M., S.M. Alessi & C.J. Rash. 2013. Contingency management treatments decrease psychiatric symptoms. J. Consult. Clin. Psychol. 81: 926-931.
115. Petry, N.M. et al. 2012. A randomized trial adapting contingency management targets based on initial abstinence status of cocaine-dependent patients. J. Consult. Clin. Psychol. 80: 276-285.
116. Petry, N.M. et al. Using contingency management to optimize outcomes based on initial abstinence status for cocaine dependent patients. J. Consult. Clin. Psychol. In press.
117. Petry, N.M., B. Martin & F. Simcic. 2005. Prize reinforcement contingency management for cocaine dependence: integration with group therapy in a methadone clinic. J. Consult. Clin. Psychol. 73: 354-359.
118. Petry, N.M., J. Weinstock & S.M. Alessi. 2011. A randomized trial of contingency management delivered in the context of group counseling. J. Consult. Clin. Psychol. 79: 686-696.
119. Petry, N.M. et al. 2004. Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom? Addiction 99: 349-360.
120. Petry, N.M. et al. 2005. Vouchers versus prizes: contingency management of treatment of substance abusers in community settings. J. Consult. Clin. Psychol. 73: 1005-1014.
121. Petry, N.M. et al. 2007. Randomized trial of contingent prizes versus vouchers in cocaine-using methadone patients. J. Consult. Clin. Psychol. 75: 983-991.
122. Petry, N.M. et al. 2006. Prize-based contingency management does not increase gambling. Drug Alcohol Depend. 83: 269-273.
123. Petry, N.M. & S.M. Alessi. 2010. Prize-based contingency management is efficacious in cocaine-abusing patients with and without recent gambling participation. J. Subst. Abuse Treat. 39: 282-288.
124. Petry, N.M., S.M. Alessi & D.M. Ledgerwood. 2012. Contingency management delivered by community therapists in outpatient settings. Drug Alcohol Depend. 122: 86-92.
125. Tai, B. et al. 2010. The first decade of the National Drug Abuse Treatment Clinical Trials Network: bridging the gap between research and practice to improve drug abuse treatment. J. Subst. Abuse Treat. 38(Suppl. 1): S4-S13.
126. Stitzer, M.L., N.M. Petry & J. Peirce. 2010. Motivational incentives research in the National Drug Abuse Treatment Clinical Trials Network. J. Subst. Abuse Treat. 38(Suppl. 1): S61-S69.
127. Martino, S. et al. 2010. Partnerships and pathways of dissemination: the National Institute on Drug Abuse-Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network. J. Subst. Abuse Treat. 38(Suppl. 1): S31-S43.
128. Petry, N.M. et al. 2005. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Arch. Gen. Psychiatry 62: 1148-1156.
129. Peirce, J.M. et al. 2006. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Arch. Gen. Psychiatry 63: 201-208.
130. Kirby, K.C. et al. 2012. Is exposure to an effective contingency management intervention associated with more positive provider beliefs? J. Subst. Abuse Treat. 42: 356-365.
131. Olmstead, T.A., J.L. Sindelar & N.M. Petry. 2007. Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs. Drug Alcohol Depend. 87: 175-182.
132. Olmstead, T.A., J.L. Sindelar & N.M. Petry. 2007. Clinic variation in the cost-effectiveness of contingency management. Am. J. Addict. 16: 457-460.
133. Sindelar, J.L., T.A. Olmstead & J.M. Peirce. 2007. Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs. Addiction 102: 1463-1471.
134. Walker, R. et al. 2010. Disseminating contingency management to increase attendance in two community substance abuse treatment centers: lessons learned. J. Subst. Abuse Treat. 39: 202-209.
135. Pilling, S., J. Strang & C. Gerada. 2007. Psychosocial interventions and opioid detoxification for drug misuse: summary of NICE guidance. BMJ 335: 203-205.
136. Petry, N.M. et al. 2013. Nationwide dissemination of contingency management: the veterans administration initiative. Am. J. Addict. 23: 205-210.
137. Rash, C.J. et al. 2012. Identifying provider beliefs related to contingency management adoption using the contingency management beliefs questionnaire. Drug Alcohol Depend. 121: 205-212.
138. Tolin, D.F. 2010. Is cognitive-behavioral therapy more effective than other therapies? A meta-analytic review. Clin. Psychol. Rev. 30: 710-720.
139. Marlatt, G.A. & J.R. Gordon. 1985. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York: Guilford.
140. Marlatt, G.A. & G.R. Gordon. 1980. "Determinants of relapse: Implications for the maintenance of behavior change." In Behavioral Medicine: Changing Health Lifestyles. P.O. Davidson & S.M. Davidson, Eds.: 410-452. New York: Brunner/Mazel.
141. Meichenbaum, D.H. 1995. "Cognitive-behavioral therapy in historical perspective." In Comprehensive Textbook of Psychotherapy: Theory and Practice. B.M. Bongar & L.E. Beutler, Eds.: 140-158. New York: Oxford University Press.
142. Chaney, E.F., M.R. O'Leary & G.A. Marlatt. 1978. Skill training with problem drinkers. J. Consult. Clin. Psychol. 46: 1092-1104.
143. Magill, M. & L.A. Ray. 2009. Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J. Stud. Alcohol Drugs 70: 516-527.
144. Anton, R.F. et al. 1999. Naltrexone and cognitive-behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am. J. Psychiatry 156: 1758-1764.
145. O'Malley, S.S. et al. 1992. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch. Gen. Psychiatry 49: 881-887.
146. Morgenstern, J. et al. 2001. Manual-guided cognitive behavioral therapy training: a promising method for disseminating empirically supported substance abuse treatments to the practice community. Psychol. Addict. Behav. 15: 83-88.
147. Carroll, K.M., S.A. Ball & S. Martino. 2004. "Cognitive, behavioral, and motivational therapies." In The American Psychiatric Publishing Textbook of Substance Abuse Treatment. 3rd ed. M. Galanter & H.D. Kleber, Eds.: 365-376. Washington DC: American Psychiatric Publishing.
148. Santa Ana, E.J. et al. 2008. What is usual about "treatment-as-usual"? Data from two multisite effectiveness trials. J. Subst. Abuse Treat. 35: 369-379.
149. Carroll, K.M. 2013. Treatment integrity and dissemination: rethinking fidelity via the Stage Model. Clin. Psychol. 20: 99-106.
150. Carroll, K.M., B.J. Rounsaville & D.S. Keller. 1991. Relapse prevention strategies in the treatment of cocaine abuse. Am. J. Drug Alcohol Abuse 17: 249-265.
151. Carroll, K.M., B.J. Rounsaville & F.H. Gawin. 1991. A comparative trial of psychotherapies for ambulatory cocaine abusers: relapse prevention and interpersonal psychotherapy. Am. J. Drug Alcohol Abuse 17: 229-247.
152. Woody, G.E. et al. 1995. Psychotherapy in community methadone programs: a validation study. Am. J. Psychiatry 152: 1302-1308.
153. Woody, G.E. et al. 1983. Psychotherapy for opiate addicts. NIDA Res. Monogr. 43: 59-70.
154. Project MATCH Research Group. 1997. Matching alcohol treatments to client heterogeneity: project MATCH posttreatment drinking outcomes. J. Stud. Alcohol 58: 7-29.
155. Carroll, K.M. et al. 1998. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction 93: 713-727.
156. Carroll, K.M. et al. 1994. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch. Gen. Psychiatry 51: 177-197.
157. Carroll, K.M. et al. 2006. The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence. J. Consult. Clin. Psychol. 74: 955-966.
158. Carroll, K.M. et al. 2004. Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Arch. Gen. Psychiatry 61: 264-272.
159. Carroll, K.M. et al. 2000. One year follow-up of disulfiram and psychotherapy for cocaine-alcohol abusers: sustained effects of treatment. Addiction 95: 1335-1349.
160. Carroll, K.M. et al. 1994. One year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: delayed emergence of psychotherapy effects. Arch. Gen. Psychiatry 51: 989-997.
161. Carroll, K.M., C. Nich & S.A. Ball. 2005. Practice makes progress: homework assignments and outcome in the treatment of cocaine dependence. J. Consult. Clin. Psychol. 73: 749-755.
162. Epstein, D.E. et al. 2003. Cognitive behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up. Psychol. Addict. Behav. 17: 73-82.
163. Anton, R.F. et al. 2005. Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence. J. Clin. Psychopharmacol. 25: 349-357.
164. O'Malley, S.S. et al. 2007. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial. Alcohol. Clin. Exp. Res. 31: 625-634.
165. Rawson, R.A. et al. 2002. A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance for cocaine dependence. Arch. Gen. Psychiatry 59: 817-824.
166. McKay, J.R. et al. 1997. Group counseling versus individualized relapse prevention aftercare following intensive outpatient treatment for cocaine dependence: initial results. J. Consult. Clin. Psychol. 65: 778-788.
167. Monti, P.M. et al. 1997. Brief coping skills treatment for cocaine abuse: substance abuse outcomes at three months. Addiction 92: 1717-1728.
168. Ito, J.R., D.M. Donovan & J.J. Hall. 1988. Relapse prevention in alcohol aftercare: effects on drinking outcome, change process and aftercare attendance. Br. J. Addict. 83: 171-181.
169. Carroll, K.M. et al. 1998. Internal validity of Project MATCH treatments: discriminability and integrity. J. Consult. Clin. Psychol. 66: 290-303.
170. Carroll, K.M. et al. 2000. A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions. Drug Alcohol Depend. 57: 225-238.
171. Carroll, K.M. et al. 1998. Internal validity of Project MATCH treatments: discriminability and integrity. J. Consult. Clin. Psychol. 66: 290-303.
172. Carroll, K.M., C. Nich & B.J. Rounsaville. 1998. Use of observer and therapist ratings to monitor delivery of coping skills treatment for cocaine abusers: utility of therapist session checklists. Psychother. Res. 8: 307-320.
173. Martino, S. et al. 2009. Correspondence of motivational enhancement treatment integrity ratings among therapists, supervisors, and observers. Psychother. Res. 19: 181-193.
174. Hogue, A. et al. In press. Validity of therapist self-report ratings of fidelity to evidence-based practices for adolescent behavior problems: correspondence between therapists and observers. Adm. Policy Ment. Health. DOI:10.1007/s10488-014-0548-2.
175. Ball, S.A. et al. 2002. Characteristics of community clinicians trained to provide manual-guided therapy for substance abusers. J. Subst. Abuse Treat. 23: 309-318.
176. Santa Ana, E.J. et al. 2009. Evaluating motivational enhancement therapy adherence and competence among Spanish-speaking therapists. Drug Alcohol Depend. 103: 44-51.
177. Sholomskas, D. et al. 2005. We don't train in vain: a dissemination trial of three strategies for training clinicians in cognitive behavioral therapy. J. Consult. Clin. Psychol. 73: 106-115.
178. Rawson, R.A. et al. 2013. Dissemination and implementation of cognitive behavioral therapy for stimulant dependence: a randomized trial comparison of 3 approaches. Subst. Abus. 34: 108-117.
179. Martino, S. et al. 2011. A criterion-based stepwise approach for training counselors in motivational interviewing. J. Subst. Abuse Treat. 40: 357-365.
180. Webb, C.A., R.J. Derubeis & J.P. Barber. 2010. Therapist adherence/competence and treatment outcome: a meta-analytic review. J. Consult. Clin. Psychol. 78: 200-211.
181. Beidnas, R.S. & P.C. Kendall. 2010. Training therapists in evidence-based practice: a critical review of studies from a systems-contextual perspective. Clin. Psychol. 17: 1-30.
182. Schoenwald, S.K., A.J. Sheidow & J.E. Chapman. 2009. Clinical supervision in treatment transport: effects on adherence and outcomes. J. Consult. Clin. Psychol. 77: 410-421.
183. Carroll, K.M. & B.J. Rounsaville. 2010. Computer-assisted therapy in psychiatry: be brave-it's a new world. Curr. Psychiatry Rep. 12: 426-432.
184. Carroll, K.M. et al. 2008. Computer-assisted cognitive-behavioral therapy for addiction. A randomized clinical trial of 'CBT4CBT'. Am. J. Psychiatry 165: 881-888.
185. Carroll, K.M. et al. 2009. Enduring effects of a computer-assisted training program for cognitive-behavioral therapy: a six-month follow-up of CBT4CBT. Drug Alcohol Depend. 100: 178-181.
186. Carroll, K.M. et al. 2014. Computer-assisted delivery of cognitive-behavioral therapy: efficacy and durability of CBT4CBT among cocaine-dependent individuals maintained on methadone. Am. J. Psychiatry 171: 436-444.
187. Hedman, E., B. Ljotsson & N. Lindefors. 2012. Cognitive behavior therapy via the Internet: a systematic review of applications, clinical efficacy and cost-effectiveness. Expert Rev. Pharmacoecon Outcomes Res. 12: 745-764.
188. McCrone, P. et al. 2004. Cost-effectiveness of computerized cognitive-behavioral therapy for anxiety and depression in primary care: randomized controlled trial. Br. J. Psychiatry 185: 55-62.
189. Olmstead, T.A., C.D. Ostrow & K.M. Carroll. 2010. Cost-effectiveness of computer-assisted training in cognitive-behavioral therapy as an adjunct to standard care for addiction. Drug Alcohol Depend. 110: 200-207.
190. Bickel, W.K. et al. 2008. Computerized behavior therapy for opioid-dependent outpatients: a randomized controlled trial. Exp. Clin. Psychopharmacol. 16: 132-143.
191. Kypri, K. et al. 2014. Web-based alcohol screening and brief intervention for university students: a randomized trial. JAMA 311: 1218-1224.
192. Marsch, L.A., W.K. Bickel & M.J. Grabinski. 2007. Application of interactive, computer technology to adolescent substance abuse prevention and treatment. Adolesc. Med. State Art Rev. 18: 342-356, xii.
193. Campbell, A.N. et al. 2014. Internet-delivered treatment for substance abuse: a multisite randomized controlled trial. Am. J. Psychiatry. 171: 683-690.
194. Hester, R.K. et al. 2009. A web application for moderation training: initial results of a randomized clinical trial. J. Subst. Abuse Treat. 37: 266-276.
195. Carey, K.B. et al. 2009. Computer-delivered interventions to reduce college student drinking: a meta-analysis. Addiction 104: 1807-1819.
196. Rooke, S. et al. 2010. Computer-delivered interventions for alcohol and tobacco use: a meta-analysis. Addiction 105: 1381-1390.
197. Tait, R.J., R. Spijkerman & H. Riper. 2013. Internet and computer based interventions for cannabis use: a meta-analysis. Drug Alcohol Depend. 133: 295-304.
198. Kiluk, B.D. et al. 2011. A methodological analysis of randomized clinical trials of computer-assisted therapies for psychiatric disorders: toward improved standards for an emerging field. Am. J. Psychiatry 168: 790-799.
199. Bickel, W.K., D.R. Christensen & L.A. Marsch. 2011. A review of computer-based interventions used in the assessment, treatment, and research of drug addiction. Substance Use Misuse 46: 4-9.
200. Olmstead, T.A. & N.M. Petry. 2009. The cost-effectiveness of prize-based and voucher-based contingency management in a population of cocaine- or opioid-dependent outpatients. Drug Alcohol Depend. 102: 108-115.
201. Madras, B.K. et al. 2009. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. Drug Alcohol Depend. 99: 280-295.
202. Miller, W.R. 2007. Bringing addiction treatment out of the closet. Addiction 102: 867.
203. Roche, A.M., C.L. Todd & J. O'Connor. 2007. Clinical supervision in the alcohol and other drugs field: an imperative or an option? Drug Alcohol Rev. 26: 241-249.
204. Karlin, B.E. & G. Cross. 2014. From the laboratory to the therapy room: National dissemination and implementation of evidence-based psychotherapies in the U.S. Department of Veterans Affairs Health Care System. Am. Psychol. 69: 19-33.
205. Glasner-Edwards, S. & R. Rawson. 2010. Evidence-based practices in addiction treatment: review and recommendations for public policy. Health Policy 97: 93-104.
206. Eby, L.T., H. Burk & C.P. Maher. 2010. How serious of a problem is staff turnover in substance abuse treatment? A longitudinal study of actual turnover. J. Subst. Abuse Treat. 39: 264-271.
207. Institute of Medicine. 2001. Crossing the Quality Chasm: A New Mental Health System for the 21st Century. Washington DC: National Academy Press.
208. McLellan, A.T., M. Chalk & J. Bartlett. 2007. Outcomes, performance, and quality: What's the difference? J. Subst. Abuse Treat. 32: 331-340.
209. Carroll, K.M. et al. 2014. Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes. Drug Alcohol Depend. 137: 3-19.
210. Fletcher, A. 2013. Inside Rehab: The Surprising Truth About Addiction New York: Treatment and Viking Press.
211. Donovan, D.M. et al. 2012. Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction 107: 694-708.
212. Humphreys, K. & A.T. McLellan. 2011. A policy-oriented review of strategies for improving the outcomes of services for substance use disorder patients. Addiction 106: 2058-2066.
213. Carroll, K.M. et al. 2014. Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes. Drug Alcohol Depend. 137C: 3-19.
214. Chassin, M.R. et al. 2010. Accountability measures-using measurement to promote quality improvement. N. Engl. J. Med. 363: 683-688.
215. McLellan, A.T. et al. 2008. Improving public addiction treatment through performance contracting: the Delaware experiment. Health Policy 87: 296-308.
216. Garnick, D.W. et al. 2012. Performance measures for substance use disorders-what research is needed? Addict. Sci. Clin. Pract. 7: 18.